Y-mAbs to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Y-mAbs TherapeuticsDec 23 13:00

We're Hopeful That Y-mAbs Therapeutics (NASDAQ:YMAB) Will Use Its Cash Wisely

Yahoo FinanceDec 20 21:48

Clear Street Launches Healthcare & Biotechnology Equity Research

BusinesswireDec 18 03:00

JonesTrading Maintains Y-mAbs Therapeutics(YMAB.US) With Buy Rating, Maintains Target Price $23

Futu NewsDec 14 04:31 · Ratings

Promising Preclinical Data on CD38-SADA Justifies Buy Rating for Y-Mabs Therapeutics

TipRanksDec 11 19:26 · Ratings

CCORF Maintains Y-mAbs Therapeutics(YMAB.US) With Buy Rating, Maintains Target Price $26

Futu NewsDec 9 21:31 · Ratings